| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9229602 | Journal of Dermatological Science | 2005 | 11 Pages |
Abstract
Taken together, these results indicate that the strong sensitizer DNFB activates ERK1/2 and p38 MAPK signaling pathways, and upregulates CD40 protein levels. However, MAPKs do not play a major role in the induction of CD40, one of the phenotypic markers of DC maturation.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Teresa J. Matos, Carlos B. Duarte, Margarida Gonçalo, M. Celeste Lopes,